These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3117876)

  • 1. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.
    den Boer JA; Westenberg HG; Kamerbeek WD; Verhoeven WM; Kahn RS
    Int Clin Psychopharmacol; 1987 Jan; 2(1):21-32. PubMed ID: 3117876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo.
    Kahn RS; Westenberg HG; Verhoeven WM; Gispen-de Wied CC; Kamerbeek WD
    Int Clin Psychopharmacol; 1987 Jan; 2(1):33-45. PubMed ID: 3312397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline.
    Den Boer JA; Westenberg HG
    Int Clin Psychopharmacol; 1988 Jan; 3(1):59-74. PubMed ID: 2833543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
    Servant D; Bailly D; Le Seac'h H; Parquet PJ
    Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of depersonalization with serotonin reuptake blockers.
    Hollander E; Liebowitz MR; DeCaria C; Fairbanks J; Fallon B; Klein DF
    J Clin Psychopharmacol; 1990 Jun; 10(3):200-3. PubMed ID: 2115893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvoxamine treatment of obsessive-compulsive disorder.
    Perse TL; Greist JH; Jefferson JW; Rosenfeld R; Dar R
    Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panic attacks and agoraphobia: low dose clomipramine treatment.
    Gloger S; Grunhaus L; Gladic D; O'Ryan F; Cohen L; Codner S
    J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
    Mundo E; Maina G; Uslenghi C
    Int Clin Psychopharmacol; 2000 Mar; 15(2):69-76. PubMed ID: 10759337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clomipramine for panic disorder: I. The first 10 weeks of a long-term comparison with imipramine.
    Cassano GB; Petracca A; Perugi G; Nisita C; Musetti L; Mengali F; McNair DM
    J Affect Disord; 1988; 14(2):123-7. PubMed ID: 2966825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
    Milanfranchi A; Ravagli S; Lensi P; Marazziti D; Cassano GB
    Int Clin Psychopharmacol; 1997 May; 12(3):131-6. PubMed ID: 9248868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL; Pigott TA
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worldwide use of clomipramine.
    Trimble MR
    J Clin Psychiatry; 1990 Aug; 51 Suppl():51-4; discussion 55-8. PubMed ID: 2199435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study.
    Klok CJ; Brouwer GJ; van Praag HM; Doogan D
    Acta Psychiatr Scand; 1981 Jul; 64(1):1-11. PubMed ID: 6172005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder.
    McTavish D; Benfield P
    Drugs; 1990 Jan; 39(1):136-53. PubMed ID: 2178909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin-influencing drugs in the treatment of panic disorder.
    Westenberg HG; den Boer JA
    Psychopathology; 1989; 22 Suppl 1():68-77. PubMed ID: 2498967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obsessive-compulsive disorder.
    March JS; Johnston H; Greist JH
    Am Fam Physician; 1989 May; 39(5):175-82. PubMed ID: 2497627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.